Conditions: Muscle Weakness
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 201
Healthy volunteers: no

Brief summary:
LY2495655 is an investigational drug being tested for muscle wasting.

Detailed description:

Arms:
arm 1: Participants received a 315-milligram (mg) dose of LY2495655, administered subcutaneously (SC), every 4 weeks (Q4W) for 20 weeks. arm 2: Participants received a LY2495655-matching dose of placebo, administered SC, Q4W for 20 weeks.

Interventions: intervention 1: LY2495655 intervention 2: Placebo
Intervention descriptions: intervention 1: Administered SC intervention 2: Administered SC

Protocol document: